메뉴 건너뛰기




Volumn 126, Issue 19, 2012, Pages 2283-2292

Apolipoprotein B Synthesis Inhibition with Mipomersen in Heterozygous Familial Hypercholesterolemia: Results of a Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety as Add-On Therapy in Patients with Coronary Artery Disease

Author keywords

apo B antisense; apolipoproteins; drug therapy; familial hypercholesterolemia; lipids

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIPOMERSEN; PLACEBO; ROSUVASTATIN; SIMVASTATIN;

EID: 84868518061     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.104125     Document Type: Article
Times cited : (263)

References (33)
  • 1
    • 0000600880 scopus 로고    scopus 로고
    • Familial hypercholesterolemia
    • Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B, eds 8th ed. New York, NY: McGraw-Hill
    • Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001:2863-2913.
    • (2001) The Metabolic and Molecular Bases of Inherited Disease , pp. 2863-2913
    • Goldstein, J.L.1    Hobbs, H.H.2    Brown, M.S.3
  • 2
    • 44849108492 scopus 로고    scopus 로고
    • Update and analysis of the university college London low density lipoprotein receptor familial hypercholesterolemia database
    • DOI 10.1111/j.1469-1809.2008.00436.x
    • Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE. Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet. 2008; 72:485-498. (Pubitemid 351850090)
    • (2008) Annals of Human Genetics , vol.72 , Issue.4 , pp. 485-498
    • Leigh, S.E.A.1    Foster, A.H.2    Whittall, R.A.3    Hubbart, C.S.4    Humphries, S.E.5
  • 3
    • 0016373413 scopus 로고
    • Coronary artery disease in 116 kindred with familial type II hyperproteinemia
    • Stone NJ, Levy RI, Fredrickson DS, Verter J. Coronary artery disease in 116 kindred with familial type II hyperproteinemia. Circulation. 1974; 49:476-488.
    • (1974) Circulation , vol.49 , pp. 476-488
    • Stone, N.J.1    Levy, R.I.2    Fredrickson, D.S.3    Verter, J.4
  • 4
    • 34548384234 scopus 로고    scopus 로고
    • Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
    • DOI 10.1016/j.jacl.2007.07.003, PII S1933287407001948
    • Stein EA, Ose L, Retterstøl K, Tonstad S, Schleman M, Harris S, Sager P. Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia. J Clin Lipidol. 2007;1: 280-286. (Pubitemid 47364514)
    • (2007) Journal of Clinical Lipidology , vol.1 , Issue.4 , pp. 280-286
    • Stein, E.A.1    Ose, L.2    Retterstol, K.3    Tonstad, S.4    Schleman, M.5    Harris, S.6    Sager, P.7
  • 5
    • 4644256971 scopus 로고    scopus 로고
    • Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
    • DOI 10.1016/j.ahj.2004.03.052, PII S0002870304002674
    • Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, MacCubbin D, Veltri E; Ezetimibe Study Group. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Am Heart J. 2004;148:447-455. (Pubitemid 39265117)
    • (2004) American Heart Journal , vol.148 , Issue.3 , pp. 447-455
    • Stein, E.1    Stender, S.2    Mata, P.3    Sager, P.4    Ponsonnet, D.5    Melani, L.6    Lipka, L.7    Suresh, R.8    MacCubbin, D.9    Veltri, E.10
  • 6
    • 77049105368 scopus 로고    scopus 로고
    • Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: A large crosssectional study in the Netherlands
    • Pijlman AH, Huijgen R, Verhagen SN, Imholz B, Liem A, Kastelein J, Abbink E, Stalenhoef, Visseren F. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large crosssectional study in the Netherlands. Atherosclerosis. 2010;209:189-194.
    • (2010) Atherosclerosis , vol.209 , pp. 189-194
    • Pijlman, A.H.1    Huijgen, R.2    Verhagen, S.N.3    Imholz, B.4    Liem, A.5    Kastelein, J.6    Abbink, E.7    Stalenhoef8    Visseren, F.9
  • 7
    • 44149123549 scopus 로고    scopus 로고
    • Recommendations for the use of LDL apheresis
    • HEART-UK LDL Apheresis Working Group
    • Thompson GR; HEART-UK LDL Apheresis Working Group. Recommendations for the use of LDL apheresis. Atherosclerosis. 2008;198: 247-255.
    • (2008) Atherosclerosis , vol.198 , pp. 247-255
    • Thompson, G.R.1
  • 8
    • 77149160366 scopus 로고    scopus 로고
    • Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia
    • Thomas T, Ginsberg H. Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia. Curr Atheroscler Rep. 2010; 12:58-65.
    • (2010) Curr Atheroscler Rep , vol.12 , pp. 58-65
    • Thomas, T.1    Ginsberg, H.2
  • 9
    • 33750207033 scopus 로고    scopus 로고
    • Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B
    • DOI 10.1161/CIRCULATIONAHA.105.606442, PII 0000301720061017000012
    • Kastelein JJ, Wedel MK, Baker BF, Su J, Bradley J, Yu R, Chuang E, Graham M, Crooke R. Potent reduction of apolipoprotein B and lowdensity lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation. 2006;114: 1729-1735. (Pubitemid 44607121)
    • (2006) Circulation , vol.114 , Issue.16 , pp. 1729-1735
    • Kastelein, J.J.P.1    Wedel, M.K.2    Baker, B.F.3    Su, J.4    Bradley, J.D.5    Yu, R.Z.6    Chuang, E.7    Graham, M.J.8    Crooke, R.M.9
  • 10
    • 77949485460 scopus 로고    scopus 로고
    • Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: A randomised, double-blind, placebocontrolled trial
    • Raal FJ, Santos RD, Blom DJ, Marais A, Charng M, Cromwell W, Lashmann R, Gaudet D, Tan J, Chasan-Taber S, Tribble D, Flaim J, Crooke S. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebocontrolled trial. Lancet. 2010;375:998-1006.
    • (2010) Lancet , vol.375 , pp. 998-1006
    • Raal, F.J.1    Santos, R.D.2    Blom, D.J.3    Marais, A.4    Charng, M.5    Cromwell, W.6    Lashmann, R.7    Gaudet, D.8    Tan, J.9    Chasan-Taber, S.10    Tribble, D.11    Flaim, J.12    Crooke, S.13
  • 12
    • 77951069859 scopus 로고    scopus 로고
    • Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia
    • Akdim F, Visser ME, Tribble DL, Baker B, Stroes E, Yu R, Flaim J, Su J, Stein E, Kastelein J. Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia. Am J Cardiol. 2010;105:1413-1419.
    • (2010) Am J Cardiol , vol.105 , pp. 1413-1419
    • Akdim, F.1    Visser, M.E.2    Tribble, D.L.3    Baker, B.4    Stroes, E.5    Yu, R.6    Flaim, J.7    Su, J.8    Stein, E.9    Kastelein, J.10
  • 13
    • 0025944056 scopus 로고
    • Risk of fatal coronary heart disease in familial hypercholesterolaemia
    • Scientific Steering Committee on behalf of the Simon Broome Register Group
    • Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ. 1991;303:893-896.
    • (1991) BMJ , vol.303 , pp. 893-896
  • 14
    • 0037126526 scopus 로고    scopus 로고
    • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III final report
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-3421.
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 16
    • 0036827347 scopus 로고    scopus 로고
    • The college of American Pathologists laboratory accreditation program
    • DOI 10.1007/s00769-002-0537-0
    • Rabinovitch A. The College of American Pathologists laboratory accreditation program. Accred Qual Assur. 2002:7;473-476. (Pubitemid 36165310)
    • (2002) Accreditation and Quality Assurance , vol.7 , Issue.11 , pp. 473-476
    • Rabinovitch, A.1
  • 17
    • 0024549783 scopus 로고
    • The Centers for Disease Control-National Heart, Lung and Blood Institute lipid standardization program. An approach to accurate and precise lipid measurements
    • Myers GL, Cooper GR, Winn CL, Smith SJ. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med. 1989;9:105-135. (Pubitemid 19070302)
    • (1989) Clinics in Laboratory Medicine , vol.9 , Issue.1 , pp. 105-135
    • Myers, G.L.1    Cooper, G.R.2    Winn, C.L.3    Smith, S.J.4
  • 18
    • 0020004724 scopus 로고
    • Dextran sulfate-Mg2-precipitation procedure for quantitation of high-density-lipoprotein cholesterol
    • Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2-precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Selected Methods Clin Clem. 1982:28;1379-1388.
    • (1982) Selected Methods Clin Clem , vol.28 , pp. 1379-1388
    • Warnick, G.R.1    Benderson, J.2    Albers, J.J.3
  • 19
    • 0028179990 scopus 로고
    • International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B IV: Comparability of apolipoprotein B values by use of international reference material
    • Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B, IV: comparability of apolipoprotein B values by use of international reference material. Clin Chem. 1994;40:586-592.
    • (1994) Clin Chem , vol.40 , pp. 586-592
    • Marcovina, S.M.1    Albers, J.J.2    Kennedy, H.3    Mei, J.V.4    Henderson, L.O.5    Hannon, W.H.6
  • 20
    • 33744506277 scopus 로고    scopus 로고
    • Drug-induced liver injury: Hy's rule revisited
    • DOI 10.1016/j.clpt.2006.02.012, PII S0009923606000841
    • Björnsson E. Drug-induced liver injury: Hy's rule revisited. Clin Pharmacol Ther. 2006;79:521-528. (Pubitemid 43817945)
    • (2006) Clinical Pharmacology and Therapeutics , vol.79 , Issue.6 , pp. 521-528
    • Bjornsson, E.1
  • 24
    • 0037069339 scopus 로고    scopus 로고
    • Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy
    • DOI 10.1161/01.CIR.0000038419.53000.D6
    • Grundy SM. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation. 2002; 106:2526-2529. (Pubitemid 35340685)
    • (2002) Circulation , vol.106 , Issue.20 , pp. 2526-2529
    • Grundy, S.M.1
  • 26
    • 39649084902 scopus 로고    scopus 로고
    • A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia
    • DOI 10.1016/j.atherosclerosis.2007.06.028, PII S0021915007004005
    • Marais AD, Raal FJ, Stein EA, Rader D, Blasetto J, Palmer M, Wilpshaar W. A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia. Atherosclerosis. 2008;197:400-406. (Pubitemid 351284477)
    • (2008) Atherosclerosis , vol.197 , Issue.1 , pp. 400-406
    • Marais, A.D.1    Raal, F.J.2    Stein, E.A.3    Rader, D.J.4    Blasetto, J.5    Palmer, M.6    Wilpshaar, W.7
  • 28
    • 0025365313 scopus 로고
    • Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia
    • Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson G, Boerwinkle E, Utermann G. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med. 1990;322:1494-1499. (Pubitemid 20179863)
    • (1990) New England Journal of Medicine , vol.322 , Issue.21 , pp. 1494-1499
    • Seed, M.1    Hoppichler, F.2    Reaveley, D.3    McCarthy, S.4    Thompson, G.R.5    Boerwinkle, E.6    Utermann, G.7
  • 29
    • 48349088178 scopus 로고    scopus 로고
    • Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
    • Samaha FF, McKenney J, Bloedon LT, Sasiela WJ, Rader DJ. Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia. Nat Clin Pract Cardiovasc Med. 2008;5:497-505.
    • (2008) Nat Clin Pract Cardiovasc Med , vol.5 , pp. 497-505
    • Samaha, F.F.1    McKenney, J.2    Bloedon, L.T.3    Sasiela, W.J.4    Rader, D.J.5
  • 30
    • 33645889332 scopus 로고    scopus 로고
    • Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
    • National Lipid Association Statin Safety Assessment Task Force
    • McKenney JM, Davidson MH, Jacobson TA, Guyton JR; National Lipid Association Statin Safety Assessment Task Force. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006;97:89C-94C.
    • (2006) Am J Cardiol , vol.97
    • McKenney, J.M.1    Davidson, M.H.2    Jacobson, T.A.3    Guyton, J.R.4
  • 31
    • 0343204478 scopus 로고    scopus 로고
    • Morris Plains NJ: Parke-Davis Division of Warner-Lambert Co
    • Lipitor [package insert]. Morris Plains, NJ: Parke-Davis Division of Warner-Lambert Co; 1997.
    • (1997) Lipitor [Package Insert]


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.